South Pars Gas Complex petrochemical facility bombed amid escalating Iran conflict Ivar AI

NPR

U.S. military says it's striking 'multiple targets' in Iran in 2nd day of renewed fire

Noticiabrasil.net.br

Estados Unidos voltam a atacar Irã após queda de helicóptero no estreito de Ormuz

The Daily Caller

US Attacks Iran After Trump Vowed Response To Lost Helicopter

Lavozdegalicia.es

Israel rompe la tregua al bombardear Beirut e Irán responde con misiles sobre territorio hebreo

Crypto Briefing

Iran launches missile volley at Israel, putting fragile ceasefire on life support

Diariobitcoin.com

Audiera ($BEAT) desafía la gravedad: ¿burbuja o nuevo paradigma cripto?

Technews.tw

英特爾股價大漲！消息指 Alphabet 已下訂 300 萬顆晶片製造訂單

Yahoo Entertainment

美國通膨創高推升升息預期黃金連兩日重挫

CNA

Nvidia announces deals with South Korea's SK Hynix, Naver and Doosan for AI data centres

Diariobitcoin.com

Binance Research: el mercado de activos tokenizados creció un 589% en apenas un año

Crypto Briefing

Israel launches airstrikes against Iran amid escalating conflict

Digitimes

AI demand is turning memory chips into rationed assets, Morgan Stanley says

Xataka.com.mx

Dreame ya se convirtió en la pesadilla de Xiaomi donde su calidad-precio era insuperable: las aspiradoras robots

SiliconANGLE News

Neura Robotics to raise up to $1.4B from Nvidia-backed consortium

New York Post

ChatGPT maker OpenAI files for IPO looking to capitalize on investor appetite for AI boom

Crypto Briefing

American Bitcoin grows BTC balance sheet to 7,021 coins, cites 50% mining margin

The Times of India

U.S. spending on rebuilding nuclear arsenal more than all other nuclear states combined including China, Russia

BBC News

EUA lançam novos ataques contra o Irã após Trump ameaçar 'atingir o país com força' diante da falta de acordo

Yahoo Entertainment

美軍空襲伊朗反擊直升機事件中東局勢動盪衝擊油市

Forbes

Global AI Buildout Proves Wealth Lode For Its Picks-And-Shovels Billionaires In Taiwan

$Cellectis reçoit le statut RMAT de la FDA pour lasmé-cel, la première thérapie CAR-T allogénique en essai pivot pour les patients atteints de LLA-B en rechute ou réfractaire$

GlobeNewswire

Cellectis reçoit le statut RMAT de la FDA pour lasmé-cel, la première thérapie CAR-T allogénique en essai pivot pour les patients atteints de LLA-B en rechute ou réfractaire